Qual é o preço para Dechra Pharmaceuticals PLC (DPH)

O preço para Dechra Pharmaceuticals PLC (DPH) é $52.60

Qual é a capitalização de mercado para Dechra Pharmaceuticals PLC (DPH)

A capitalização de mercado para Dechra Pharmaceuticals PLC (DPH) é $59.92M

Receita de Dechra Pharmaceuticals PLC (DPH)

Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.

Ano	Receita	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Receita

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Receita	Diferença de Receita	País
Eli Lilly and Company LLY.US	$79.67B	-	US
Johnson & Johnson JNJ.US	$97.93B	-	US
AbbVie Inc. ABBV.US	$64.39B	-	US
Roche Holding AG RO.SW	$77.52B	-	CH
Merck & Co., Inc. MRK.US	$66.40B	-	US

Empresa

Receita

Diferença de Receita

País